Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT05303792 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05303792
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-09
- Primary completion
- 2027-04-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.